Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

KW DRUG DEVELOPMENTS LTD Active

Scientific & Education


2005-06-30

Private limited company (Ltd.)

2 Shareholders
View all shareholders »

05496002

Research and experimental development on social sciences and humanities (72200)

Scientific & Education
Research
Education & Training
Nonprofit Organisations
Charities

KW DRUG DEVELOPMENTS LTD is a Private limited company (Ltd.) company based in PROGRESS HOUSE, 396 WILMSLOW RD WITHINGTON, United Kingdom, which employs 1 people. The company started trading on 30 June 2005. The company registration number is 05496002, It’s main line of business activity is Research and experimental development on social sciences and humanities, and the company is listed as Active. According to the latest confirmation statements submitted on the 2021-03-31, there are currently 1 directors.

Contact information


This information is available only for subscribed users

+44··········
+44··········
··········@·····.com
···············.com

PROGRESS HOUSE, 396 WILMSLOW RD WITHINGTON , M20 3BN , United Kingdom

United Kingdom

Financial statements of KW DRUG DEVELOPMENTS LTD

According to KW DRUG DEVELOPMENTS LTD latest financial report submitted on 2021-03-31, the company has a Cash of £18,175.00, Total-Assets of £20,015.00 while the Working-Capital is -£246.00. Compared with the previous year, the company reported a Cash increase of 3.22%, which is an equivalent of -585. At the same time, the Total-Assets went up by 1.62%, or by -325.



Consolidated A/cs

For more information you can

Turnover 2021

£ -

  • Consolidated A/cs

    N

  • Reporting period

    12

  • Working Capital

    £ -246

  • Profit after Tax

    £ -

Reporting period

KW DRUG DEVELOPMENTS LTD Business Credit Report

A Business Credit Report for KW DRUG DEVELOPMENTS LTD is available for instant download. The report will provide you with a credit score and credit limit recommendation for KW DRUG DEVELOPMENTS LTD, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

KW DRUG DEVELOPMENTS LTD

80

Get this credit report

for £30

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

KW DRUG DEVELOPMENTS LTD Directors and key executives

KW DRUG DEVELOPMENTS LTD currently employs 1 people. Compared with the previous year, the company has reported a staff increase of 0%, which is an equivalent of 0 employees.
In order to view contact information, including emails and phone numbers for all the employees working at KW DRUG DEVELOPMENTS LTD and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

1

100%

1y growth

100%

2y growth

Management Level


100

Middle

×

Get direct emails & phone numbers for senior executives working at «KW DRUG DEVELOPMENTS LTD»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.
Employee Job Title Email Phone Country
Jane Williams Company Secretary
-
- GB
Keith Williams Director
-
- GB

Get in touch with 2 of contacts working at KW DRUG DEVELOPMENTS LTD

KW DRUG DEVELOPMENTS LTD Shareholders

There are currently 2 people with significant control at KW DRUG DEVELOPMENTS LTD. One of of major shareholders of KW DRUG DEVELOPMENTS LTD is MRS JANE WILLIAMS, which owns 1 ORDINARY shares, with a total value of 1 GBP and DR KEITH JOHN WILLIAMS, which owns 1 ORDINARY shares, with a total value of 1 GBP.


Name Quantity Share Type Value
MRS JANE WILLIAMS 1 ORDINARY 1 GBP
DR KEITH JOHN WILLIAMS 1 ORDINARY 1 GBP

KW DRUG DEVELOPMENTS LTD competitors:

Top 5 similar companies of KW DRUG DEVELOPMENTS LTD are HENLEY CENTRE HEADLIGHT VISION LTD, LSE ENTERPRISE LTD, LABOUR RESEARCH DEPARTMENT, NEW POLICY INSTITUTE, COUNCIL FOR BRITISH RESEARCH IN THE LEVANT. View and export all the competitor list of KW DRUG DEVELOPMENTS LTD by upgrading your account here.


HENLEY CENTRE HEADLIGHT VISION LTD


Revenue
-
Age
36 years
Employees
2
Industry
View Marketing consultants
Website
View http://www.thefut***************

LSE ENTERPRISE LTD


Revenue
5,903,418.0
Age
31 years
Employees
26
Industry
View Scientific & Education
Website
View http://ls*******

LABOUR RESEARCH DEPARTMENT


Revenue
796,964.0
Age
4 years
Employees
13
Industry
View Scientific & Education
Website
View -

NEW POLICY INSTITUTE


Revenue
-
Age
25 years
Employees
4
Industry
View Scientific & Education
Website
View npi.or****

COUNCIL FOR BRITISH RESEARCH IN THE LEVANT


Revenue
895,407.0
Age
24 years
Employees
14
Industry
View Scientific & Education
Website
View http://cbr********

KW DRUG DEVELOPMENTS LTD news & activities:


EBITDA

The KW DRUG DEVELOPMENTS LTD-based company said the adjusted EBITDA is now £259.00, compared with the previous year of 252.

uk.globaldatabase.com

2022-03-31

Employees

KW DRUG DEVELOPMENTS LTD number of employees has decreased by 0% compared with previous year and now represents a total number of 1.

uk.globaldatabase.com

2022-03-31

Frequently Asked Questions regarding KW DRUG DEVELOPMENTS LTD


Where is KW DRUG DEVELOPMENTS LTD registered office?

KW DRUG DEVELOPMENTS LTD is located at PROGRESS HOUSE, 396 WILMSLOW RD WITHINGTON, United Kingdom.

How many people work at KW DRUG DEVELOPMENTS LTD?

According to the latest account statement, there are currently 1 of employees working for KW DRUG DEVELOPMENTS LTD.

What is KW DRUG DEVELOPMENTS LTD EBITDA?

For 2021, KW DRUG DEVELOPMENTS LTD has reported an EBITDA of £259.00, which went down by -2.7% compared to previous year.

What is the Business Credit Score of KW DRUG DEVELOPMENTS LTD and how reliable is the company?

In order to check the business credit score of KW DRUG DEVELOPMENTS LTD, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does KW DRUG DEVELOPMENTS LTD pay their invoices on time?

By requesting a Business Credit Report for KW DRUG DEVELOPMENTS LTD, you will be able to gain more insights about the KW DRUG DEVELOPMENTS LTD payment trends.

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action